drugset / Trial / NCT05465668

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

NCT05465668 ↗

Phase 1 Completed 43 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the safety and pharmacokinetic characteristics after administration of DWP16001 Drug A and DWP16001 Drug C in healty adult volunteers.

Timeline

Start
2022-07-22
Primary completion
2022-08-16
Completion
2022-11-22

Drugs

EvaluationDrugModalityDoseRoute
Subject DWP16001 Drug A Unknown — Oral
Subject DWP16001 Drug C Unknown — Oral

Indications

No indication recorded.